바이오마린제약(주)
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionLPL Financial LLC
Latest Disclosed Ownership39,732 shares
Latest Disclosed Value $ 2,244,461
LPL Financial LLC reports 60.26% increase in ownership of BMRN / BioMarin Pharmaceutical Inc.

On May 6, 2026 - LPL Financial LLC filed a 13F-HR form disclosing ownership of 39,732 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $2,244,461 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 24,792 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 60.26% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,732 14,940 60.26 2,244 52.34 0.0006
2026-02-11 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,792 -6,936 -21.86 1,473 -14.26 0.0004
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,728 -5,070 -13.78 1,718 -15.03 0.0005
2025-08-12 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 36,798 -27,378 -42.66 2,023 -55.42 0.0007
2025-05-07 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 64,176 32,903 105.21 4,537 120.73 0.0018
2025-02-11 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,273 -1,701 -5.16 2,056 -11.31 0.0008
2024-11-08 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,974 1,541 4.90 2,318 -10.44 0.0010
2024-08-07 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,433 -1,049 -3.23 2,588 -8.78 0.0013
2024-05-10 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,482 1,258 4.03 2,837 -5.78 0.0015
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,224 432 1.40 3,011 10.50 0.0018
2023-11-13 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,792 3,982 14.85 2,724 17.26 0.0019
2023-07-31 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 26,810 1,412 5.56 2,324 -5.91 0.0017
2023-05-10 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,398 -289 -1.13 2,470 -7.11 0.0019
2023-02-07 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,687 -859 -3.24 2,658 18.13 0.0023
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 26,546 -3,163 -10.65 2,250 -8.61 0.0022
2022-08-12 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 29,709 -2,280 -7.13 2,462 -0.16 0.0023
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,989 -34,492 -51.88 2,466 -58.05 0.0021
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 66,481 -5,610 -7.78 5,878 5.55 0.0049
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 72,091 7,424 11.48 5,569 3.21 0.0052
2021-08-13 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 64,667 -8,082 -11.11 5,396 -1.77 0.0055
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 72,749 6,731 10.20 5,493 -5.11 0.0063
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 66,018 17,994 37.47 5,789 58.43 0.0075
2020-11-09 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 48,024 136 0.28 3,654 -38.14 0.0057
2020-08-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 47,888 4,045 9.23 5,907 59.43 0.0103
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 43,843 5,059 13.04 3,705 13.03 0.0080
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 38,784 -1,322 -3.30 3,278 21.27 0.0060
2019-11-13 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 40,106 -2,851 -6.64 2,703 -26.47 0.0055
2019-08-09 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 42,957 8,547 24.84 3,676 20.25 0.0078
2019-05-08 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,410 4,404 14.68 3,057 19.65 0.0069
2019-02-07 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,006 1,263 4.39 2,555 -8.32 0.0068
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,743 -781 -2.65 2,787 0.22 0.0067
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 29,524 19,790 203.31 2,781 252.47 0.0073
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,734 -2,624 -21.23 789 -28.47 0.0022
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,358 -1,393 -10.13 1,103 -13.29 0.0034
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,751 203 1.50 1,272 4.01 0.0045
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,548 10,216 306.60 1,223 320.27 0.0046
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,332 750 29.05 291 33.49 0.0020
2017-02-13 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,582 2,582 0.00 218 0.0017
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -6,244 -100.00 0 -100.00
2016-05-16 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,244 -2,457 -28.24 518 -42.51 0.0014
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,701 2,851 48.74 901 40.56 0.0025
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,850 649 12.48 641 -11.83 0.0035
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,201 1,275 32.48 727 53.05 0.0037
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,926 1,561 66.00 475 121.96 0.0024
2015-02-13 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,365 -1,438 -37.81 214 -20.15 0.0012
2014-11-10 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,803 -8,631 -69.41 268 -65.37 0.0016
2014-08-05 2014-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 12,434 -3,284 -20.89 774 -27.80 0.0045
2014-08-05 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,434 1,693
2014-05-12 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,718 3,327 26.85 1,072 22.94 0.0066
2014-02-13 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,391 5,438 78.21 872 84.36 0.0054
2013-11-04 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,953 6,953 473 0.0031
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.